Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Autor: Gerstein, Hertzel C1 (AUTHOR) gerstein@mcmaster.ca, Colhoun, Helen M2 (AUTHOR), Dagenais, Gilles R3 (AUTHOR), Diaz, Rafael4 (AUTHOR), Lakshmanan, Mark5 (AUTHOR), Pais, Prem6 (AUTHOR), Probstfield, Jeffrey7 (AUTHOR), Botros, Fady T5 (AUTHOR), Riddle, Matthew C8 (AUTHOR), Rydén, Lars9 (AUTHOR), Xavier, Denis6 (AUTHOR), Atisso, Charles Messan5 (AUTHOR), Dyal, Leanne1 (AUTHOR), Hall, Stephanie1 (AUTHOR), Rao-Melacini, Purnima1 (AUTHOR), Wong, Gloria1 (AUTHOR), Avezum, Alvaro10 (AUTHOR), Basile, Jan11 (AUTHOR), Chung, Namsik12 (AUTHOR), Conget, Ignacio13 (AUTHOR)
Zdroj: Lancet. Jul2019, Vol. 394 Issue 10193, p131-138. 8p.
Databáze: Business Source Ultimate